Treatment of Perianal Crohn's Disease, Combining Medical and Surgical Treatment.

Discontinuation of Infliximab Therapy in Patients With Crohn's Disease During Sustained Complete Remission

NCT01817426 ·Status: COMPLETED ·Phase: PHASE4

Monoclonal Antibody Treatment of Crohn's Disease

NCT00007163 ·Status: COMPLETED ·Phase: PHASE1

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

NCT00851565 ·Status: UNKNOWN ·Phase: PHASE4

An Open Label, Prospective, One Arm, Feasibility, Study for The Use of Halevy Kit for the Treatment of Perianal Fistulas in Patients With Crohn's Disease

NCT00653094 ·Status: UNKNOWN ·Phase: NA

Impact of the Fecal Flora Transplantation on Crohn's Disease

NCT02097797 ·Status: COMPLETED ·Phase: NA

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Fistulizing Crohn's Disease

NCT00269841 ·Status: COMPLETED ·Phase: PHASE3

Infliximab, Regulatory T Cells, IL2 and Crohn's Disease

NCT01266785 ·Status: WITHDRAWN ·Phase: NA

Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease

NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Anti TNF α Improves Endothelial Dysfunction in IBD Patients

NCT01881464 ·Status: UNKNOWN

Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease

NCT04974099 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

NCT02247258 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of Treatment With Interferon Beta-1a Rebif® in Patients With Crohn's Disease

NCT00304252 ·Status: TERMINATED ·Phase: PHASE2

Managing Infliximab Reinduction After Temporary Discontinuation of Drug

NCT02771457 ·Status: WITHDRAWN ·Phase: PHASE3

An Efficacy and Safety Study of Anti-TNF Monoclonal Antibody in Patients With Crohn's Disease

NCT00269854 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease

NCT01559142 ·Status: UNKNOWN ·Phase: PHASE3

Improving Treatment of Inflammatory Bowel Diseases Through Better Understanding Infliximab Drug and Antibody Levels

NCT01787786 ·Status: WITHDRAWN

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

NCT02403323 ·Status: TERMINATED ·Phase: PHASE3

Immune Ablation and Stem Cell Support for Crohn's Disease

NCT00179842 ·Status: WITHDRAWN ·Phase: PHASE2

Treatment With Infliximab in a Medical Setting (Study P05587)

NCT00752622 ·Status: TERMINATED ·Phase: PHASE4

Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease

NCT01438151 ·Status: TERMINATED ·Phase: NA

The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera Endoscopy

NCT01181765 ·Status: COMPLETED ·Phase: PHASE4

A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials

NCT04362254 ·Status: TERMINATED ·Phase: PHASE2

Fecal Transplantation for Inflammatory Bowel Disease

NCT02391012 ·Status: TERMINATED ·Phase: PHASE1

HLADQA1*05 Genotype and the Efficacy of Treatment With Infliximab in Chinese Population Crohn's Disease

NCT05813860 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Top-down Infliximab Study in Kids With Crohn's Disease

NCT02517684 ·Status: COMPLETED ·Phase: PHASE4